Skip to content

The predictive role of systemic immune inflammation index in obstructive sleep apnea syndrome patients underwent adenotonsillectomy

The predictive role of systemic immune inflammation index in obstructive sleep apnea syndrome patients underwent adenotonsillectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105372
Enrollment
Unknown
Registered
2025-07-02
Start date
2025-07-03
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea syndrome

Interventions

Health control group:None

Sponsors

Shanghai Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: OSA Group: 1. Age 3-18 years old; 2. All children were diagnosed with OSA (confirmed by polysomnography) before surgery; 3. The child had OSA symptoms such as sleep snoring, mouth breathing, and nocturnal awakening; 4. Diagnosis of tonsillar hypertrophy and adenoid hypertrophy; 5. All family members of the affected children signed the informed consent form. Control group: 1. Age 3-18 years old; 2. The child has no obvious inflammatory, infectious or tumor diseases in the preoperative diagnosis, such as congenital ear attachment, sensorineural hearing loss, small masses on the body surface and other diseases; 3. The child had no obvious OSA symptoms; 4. All family members of the child signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Respiratory tract infection (within 2 weeks) in the short period before surgery; 2. The child has obvious neurological developmental disorders, congenital developmental abnormalities, etc.; 3. The child has a hematologic disorder; 4. The child has contraindications to general anesthesia; 5. History of malignant tumor disease in the child; 6. The family members of the children do not agree to be enrolled in this clinical study.

Design outcomes

Primary

MeasureTime frame
The presence of obstructive sleep apnea syndrome;The severity of obstructive sleep apnea syndrome;

Secondary

MeasureTime frame
Postoperative bleeding;Postoperative fever;Postoperative pain;

Countries

China

Contacts

Public ContactXie Zhibo

Shanghai Children's Hospital

jxncxzb@163.com+86 159 2168 2847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026